Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

Mundipharma gets European rights to SkyePharma's Flutiform

Executive Summary

SkyePharma PLC (oral, injectable, topical, and inhalation drug delivery) has licensed UK pharma company Mundipharma exclusive rights to develop, sell, and distribute Phase III Flutiform for asthma and COPD in Europe and certain international territories outside of North, Central, and South America.
Deal Industry
  • Biotechnology
  • Medical Devices
  • Pharmaceuticals
    • Drug Delivery
      • Pulmonary
Deal Status
  • Final
Deal Type
  • Alliance
    • R+D and Marketing-Licensing
    • Includes Royalty or Profit Split Information

Related Companies